[1] |
Rajkumar SV, Dimopoulos MA, Palumbo A, et al.
International Myeloma Working Group Updated criteria for the diagnosis of multiple myeloma[J]. Lancet OncolLancet Oncol, 2014, 15(12): e538-e548.
doi: 10.1016/S1470-2045(14)70442-5 |
[2] |
Durie BGM.
The role of anatomic and functional staging in myeloma: description of Durie/Salmon plus staging system[J]. Eur J CancerEur J Cancer, 2006, 42(11): 1539-1543.
doi: 10.1016/j.ejca.2005.11.037 |
[3] |
中国医师协会血液科医师分会, 中华医学会血液学分会, 中国医师协会多发性骨髓瘤专业委员会.
中国多发性骨髓瘤诊治指南(2017年修订)[J]. 中华内科杂志中华内科杂志, 2017, 56(11): 866-870.
doi: 10.3760/cma.j.issn.0578-1426.2017.11.021 Chinese Hematology Association, Chinese Society of Hematology, Chinese Myeloma Committee-Chinese Hematology Association. The guidelines for the diagnosis and management of multiple myeloma in China (2017 revision)[J]. Chin J Intern MedChin J Intern Med, 2017, 56(11): 866-870. doi: 10.3760/cma.j.issn.0578-1426.2017.11.021 |
[4] |
Breyer III RJ, Mulligan ME, Smith SE, et al.
Comparison of imaging with FDG PET/CT with other imaging modalities in myeloma[J]. Skeletal RadiolSkeletal Radiol, 2006, 35(9): 632-640.
doi: 10.1007/s00256-006-0127-z |
[5] |
Engelhardt M, Kleber M, Udi J, et al.
Consensus statement from European experts on the diagnosis, management, and treatment of multiple myeloma: from standard therapy to novel approaches[J]. Leuk LymphomaLeuk Lymphoma, 2010, 51(8): 1424-1443.
doi: 10.3109/10428194.2010.487959 |
[6] |
中华医学会血液学分会.
多发性骨髓瘤骨病诊治指南[J]. 中华血液学杂志中华血液学杂志, 2011, 32(10): 721-723.
doi: 10.3760/cma.j.issn.0253-2727.2011.10.023 Chinese Society of Hematology. The guidelines for the diagnosis and management of multiple myeloma bone disease[J]. Chin J HematolChin J Hematol, 2011, 32(10): 721-723. doi: 10.3760/cma.j.issn.0253-2727.2011.10.023 |
[7] |
Narquin S, Ingrand P, Azais I, et al. Comparison of whole-body diffusion MRI and conventional radiological assessment in the staging of myeloma[J/OL]. Diagn Interv Imaging, 2013, 94(6): 629-636[2018-08-20].https://www.ncbi.nlm.nih.gov/pubmed/23683788. DOI: 10.1016/j.diii.2013.01.005. |
[8] |
Dammacco F, Rubini G, Ferrari C, et al.
18F-FDG PET/CT: a review of diagnostic and prognostic features in multiple myeloma and related disorders[J]. Clin Exp MedClin Exp Med, 2015, 15(1): 1-18.
doi: 10.1007/s10238-014-0308-3 |
[9] |
Moon SH, Choi WH, Yoo IR, et al.
Prognostic Value of Baseline 18F-Fluorodeoxyglucose PET/CT in Patients with Multiple Myeloma: A Multicenter Cohort Study[J]. Korean J RadiolKorean J Radiol, 2018, 19(3): 481-488.
doi: 10.3348/kjr.2018.19.3.481 |
[10] |
Fonti R, Salvatore B, Quarantelli M, et al.
18F-FDG PET/CT, 99mTc-MIBI, and MRI in Evaluation of Patients with Multiple Myeloma[J]. J Nucl MedJ Nucl Med, 2008, 49(2): 195-200.
doi: 10.2967/jnumed.107.045641 |
[11] |
Lu YY, Chen JH, Lin WY, et al.
FDG PET or PET/CT for Detecting Intramedullary and Extramedullary Lesions in Multiple Myeloma: A Systematic Review and Meta-analysis[J]. Clin Nucl MedClin Nucl Med, 2012, 37(9): 833-837.
doi: 10.1097/RLU.0b013e31825b2071 |
[12] |
Murthy NJ, Rao H, Friedman AS.
Positive findings on bone scan in multiple myeloma[J]. South Med JSouth Med J, 2000, 93(10): 1028-1029.
doi: 10.1097/00007611-200093100-00018 |
[13] |
陈婷, 刘超, 邓智勇.
多发性骨髓瘤双肺弥漫性摄取99Tcm-MDP一例[J]. 国际放射医学核医学杂志国际放射医学核医学杂志, 2018, 42(1): 87-89.
doi: 10.3760/cma.j.issn.1673-4114.2018.01.017 Chen T, Liu C, Deng ZY. Diffuse bilateral pulmonary uptake 99Tcm-MDP in a patient with multiple myeloma: a case report[J]. Int J Radiat Med Nucl MedInt J Radiat Med Nucl Med, 2018, 42(1): 87-89. doi: 10.3760/cma.j.issn.1673-4114.2018.01.017 |
[14] |
Zhang SM, Chen Y, Huang ZW, et al.
Significant 99mTc-MDP but Unimpressive 18F-NaF Gastric Activity in a Patient with Multiple Myeloma[J]. Clin Nucl MedClin Nucl Med, 2016, 41(9): 740-742.
doi: 10.1097/RLU.0000000000001311 |